| 236 | 1 | 102 |
| 下载次数 | 被引频次 | 阅读次数 |
目的:观察基于六经辨证方法治疗多重耐药菌(MDRO)肺部感染的临床疗效,为治疗该病提供中医辨证治疗思路。方法:选取2020—2021年广州市番禺区中医院呼吸与危重症医学科、重症医学科诊断为MDRO肺部感染的70例患者为研究对象,采用随机数字表法分为治疗组、对照组。对照组根据病原体类型选择相应药物抗感染治疗,治疗组在对照组基础上联合六经辨证治疗。以炎症指标(白细胞、降钙素原、C反应蛋白)、肺炎严重程度指数、细菌清除率、氧合指数、退热时间及住院天数作为疗效指标,观察两组患者治疗效果。结果:治疗后,治疗组总有效率高于对照组,肺炎严重程度指数评分低于对照组(P<0.05);在炎症指标方面治疗组低于对照组,两组比较差异有统计学意义(P<0.05);治疗组细菌清除率高于对照组(P<0.05);两组患者氧合指数水平比较治疗组显著高于对照组,差异有统计学意义(P<0.01);治疗组退热时间及住院天数明显低于对照组(P<0.01)。结论:对MDRO肺部感染患者进行六经辨证诊治可获得较好的临床疗效,降低病情严重程度,降低炎症水平,提高细菌清除率,改善氧合指数,值得临床推广。
Abstract:Objective:To observe the clinical effect of the treatment of multidrug resostant organism(MDRO) pulmonary infection based on the six channels syndrome differentiation method,and to provide traditional Chinese medicine(TCM) syndrome differentiation and treatment ideas for this disease.Methods:A total of 70 patients diagnosed as MDRO pulmonary infection in the Department of Respiratory and Critical Care Medicine and the Department of Critical Care Medicine of Panyu District Hospital of Traditional Chinese Medicine of Guangzhou from 2020 to 2021 were collected as the study subjects,and were divided into the treatment group and the control group by random number table method. The control group was treated by corresponding drugs for anti infection according to the type of pathogens,and the treatment group was combined with syndrome differentiation of six channels on the basis of the treatment of the control group. Inflammatory indicators(leukocyte,procalcitonin,C-reactive protein),pneumonia severity index,bacterial clearance rate,oxygenation index,duration of fever reduction and hospital stay were used as therapeutic indicators to observe the therapeutic effect of the two groups. Results:After treatment,the total effective rate of the treatment group was higher than that of the control group,and the score of pneumonia severity index of the treatment group was lower than that of the control group(P<0.05). In terms of inflammation indexes,there was statistical difference between the two groups,and the treatment group was lower than the control group(P<0.05).The bacterial clearance rate in the treatment group was higher than that in the control group(P<0.05).There was statistical difference in oxygenation index between the two groups,and the treatment group was significantly higher than the control group(P<0.01). The duration of fever and hospitalization in the treatment group were significantly lower than those in the control group(P<0.01). Conclusions:The six channels syndrome differentiation and treatment of MDRO patients with pulmonary infection can obtain better clinical effect,reduce the severity of the disease,reduce the level of inflammation,increase the bacterial clearance rate,and improve the oxygenation index,which is worthy of clinical promotion.
[1]杜明梅,邢玉斌,索继江,等.多重耐药菌医院感染的实时监测与预防控制[J].中国医院,2013,17(3):3-5.
[2]瞿介明,曹彬.中国成人社区获得性肺炎诊断和治疗指南(2016年版)修订要点[J].中华结核和呼吸杂志,2016,39(4):241-242.
[3]余学庆,谢洋,李建生.社区获得性肺炎中医诊疗指南(2018修订版)[J].中医杂志,2019,60(4):350-360.
[4]中华医学会呼吸病学分会.中国成人社区获得性肺炎诊断和治疗指南(2016年版)[J].中华结核和呼吸杂志,2016,39(4):253-279.
[5]姚乃礼.中医症状鉴别诊断学[M]. 2版.北京:人民卫生出版社,2000.
[6]邓铁涛.中医诊断学[M].上海:上海科学技术出版社,1988.
[7]罗胜,梁结柱,冼宙宁,等.重症医学科多重耐药菌肺部感染的中医证候特征研究[J].湖南中医杂志,2017,33(9):1-5.
[8]施经伟,张田,周和平,等.白虎汤加减治疗脑卒中并发多重耐药菌所致肺炎的效果[J].广东医学,2017,38(S2):148-150.
[9]汪玲琴,蒋忠胜.社区获得性肺炎严重程度评分系统的研究进展[J].江苏大学学报(医学版),2019,29(1):87-92.
[10]苏丽,梁婷.美罗培南与万古霉素治疗耐甲氧西林金黄色葡萄球菌感染的疗效、炎性因子及安全性分析[J].医学理论与实践,2023,36(18):3121-3123.
[11]韩春兰,魏海霞.替加环素联合多粘菌素治疗多重耐药菌肺部感染患者的临床疗效分析[J].中国合理用药探索,2021,18(9):90-94.
[12]陈佰义,何礼贤,胡必杰,等.中国鲍曼不动杆菌感染诊治与防控专家共识[J].中国医药科学,2012,2(8):3-8.
[13]颜芳,杨志敏,徐国峰,等.运用经方纯中医治疗肺部感染102例[C]//中华中医药学会.国际(中日韩)经方学术会议暨第二届全国经方论坛暨经方应用高级研修班论文集.北京:北京出版社,2011:105-108.
[14]吴文斌,颜芳,徐国峰,等.从六经辨证入手治疗肺部感染体会[J].新中医,2011,43(7):151-152.
[15]张静,刘冬,许西琳,等.红细胞分布宽度与成人社区获得性肺炎严重程度的相关性分析[J].中国呼吸与危重监护杂志,2018,17(2):134-137.
[16]焦妃,冯涛,王浩,等.扶正透邪法治疗肺部多重耐药菌感染的临床观察[J].中国中医急症,2023,32(8):1423-1425.
[17]陈鹏,庞健健,付慧,等.重症肺炎患者血清氧化应激指标和炎症因子的表达及其与肺部感染评分的关系[J].现代生物医学进展,2019,19(9):1778-1781.
[18]钱旭胜,李碧芳,陶海澜,等.喘可治注射液联合高流量呼吸湿化治疗仪治疗慢性阻塞性肺疾病急性加重期合并呼吸衰竭的临床效果[J].中国当代医药,2021,28(31):168-172.
[19]童岷奎,叶蕾.浅析血清C反应蛋白、降钙素原、纤维蛋白原对老年肺部感染的预测效果[J].当代医学,2022.,28(4):137-139.
[20]刘岩峰.降钙素原、C-反应蛋白与肺部感染多重耐药鲍曼不动杆菌患者病情相关性研究[J].河北医药,2020,42(19):2947-2949,2953.
[21]殷国敏,周剑,袁长广.麻杏石甘汤联合西医常规治疗老年肺部感染临床研究[J].新中医,2022,54(6):19-22.
[22]郭金汶.麻杏石甘汤加减治疗肺热型社区获得性肺炎临床观察[J].中国中医药现代远程教育,2023,21(11):109-111.
[23]魏江存,陈勇,谢臻,等.大承气汤的药理作用研究概况[J].中国民族民间医药,2017,26(21):70-72,74.
[24]贾音,任晨曦,夏悠楠,等.厚朴酚的药理作用研究现状[J].生物化工,2023,9(3):170-174.
[25]刘浩,曲妮妮.痰热清注射液联合西药治疗老年多重耐药菌肺炎患者的临床疗效[J].中国实验方剂学杂志,2021,27(24):125-130.
[26]崔磊,陈楠,颜琳,等.培土生金方治疗肺部多重耐药菌感染疗效研究[J].陕西中医,2023,44(8):1082-1085.
[27]王懿勤,马春成.白虎汤加减联合全面护理对重症肺炎伴高热患者肺功能与生化指标的影响[J].现代医学与健康研究电子杂志,2022,6(4):132-135.
基本信息:
DOI:10.16295/j.cnki.0257-358x.2024.08.010
中图分类号:R259
引用信息:
[1]江婷,王温欣,罗潇潇,等.基于六经辨证理论治疗多重耐药菌肺部感染疗效评价[J].山东中医杂志,2024,43(08):835-841.DOI:10.16295/j.cnki.0257-358x.2024.08.010.
基金信息:
广东省基础与应用基础研究基金项目(编号:2022B1515230001); 广州市番禺区医疗卫生项目一般项目(编号:2019-Z04-70)
2024-08-05
2024-08-05